The cross-talk between insulin and IGF1 signaling also contributes to physiological cardiac hypertrophy, with defects in IGF1 signaling exacerbating exercise-induced hypertrophy, as evidenced by studies on mice with cardiomyocyte-specific deletions of IGF1R and IRS. Here, IGF1 is linked to cardiac hypertrophy.